Table 1.
Epidermal atrophy | Papillary dermis fibrosis | ||||
---|---|---|---|---|---|
Normal | 0 | More than seven layers | Normal | 0 | Absence |
Light | 1 | Six to seven layers | Light | 1 | Reduction in thickness of lax tissue |
Moderate | 2 | Four to five layers | Moderate | 2 | Segmental hyalinization |
Severe | 3 | Three layers or less | Severe | 3 | Complete hyalinization |
Dermal and subcutaneous infiltration | Reticular dermis fibrosis | ||||
Normal | 0 | Absence | Normal | 0 | Absence |
Light | 1 | Isolated lymphocytes | Light | 1 | Small pockets of hyalinization |
Moderate | 2 | Small groups of lymphocytes | Moderate | 2 | Presence of moderate hyalinization |
Severe | 3 | Large groups of lymphocytes | Severe | 3 | Total hyalinization |
Adipose tissue fibrosis | Annex atrophy | ||||
Normal | 0 | Absence | Normal | 0 | Absence |
Light | 1 | Light thickening of adipose septa | Light | 1 | Periadnexal fibrosis |
Moderate | 2 | Moderate thickening of adipose septa | Moderate | 2 | Reduction in size of annexes |
Severe | 3 | Severe thickening of adipose septa | Severe | 3 | Presence of adnexal vestiges |
aMicroscopic characteristics that were used as parameters to evaluate the effectiveness of pirfenidone on localized scleroderma lesions.